Deep Track Capital, LP

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 69
Total Value: 3088173822
Accession Number: 0001856083-25-000002
Form Type: 13F-HR
CIK: 0001856083
Manager Name: Deep Track Capital, LP

Data Enrichment

93% identified

64 identified5 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

69 positions • $3,088,173.822K total value

69 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 3 of 4

Sort by:

Sage Therapeutics, Inc.

SAGE|78667J108

2038845

Value:

$16.2B

Terns Pharmaceuticals, Inc.

TERN|880881107

5576558(+0.0%)

Value:

$15.4B(-50.2%)

Korro Bio, Inc.

KRRO|500946108

874614(+0.0%)

Value:

$15.2B(-54.3%)

Oruka Therapeutics, Inc.

ORKA|687604108

1444709(+92.6%)

Value:

$14.8B(+1.9%)

Mind Medicine (MindMed) Inc.

MNMD|60255C885

2500000(-11.2%)

Value:

$14.6B(-25.4%)

Upstream Bio, Inc.

UPB|91678A107

2299567(+129.9%)

Value:

$14.1B(-14.4%)

Olema Pharmaceuticals, Inc.

OLMA|68062P106

3442833(+0.0%)

Value:

$12.9B(-35.5%)

Septerna, Inc.

SEPN|81734D104

1912929(+0.0%)

Value:

$11.1B(-74.7%)

NOVAVAX INC

NVAX|670002401

1518182(-24.1%)

Value:

$9.7B(-39.5%)

CYBIN INC.

CYBN|23256X407

1529987(+0.0%)

Value:

$9.7B(-28.1%)

RAPT Therapeutics, Inc.

RAPT|75382E109

6011380(+0.0%)

Value:

$7.3B(-22.8%)

PLIANT THERAPEUTICS, INC.

PLRX|729139105

5399681(-9.6%)

Value:

$7.3B(-90.7%)

Avalo Therapeutics, Inc.

AVTX|05338F306

859876(-0.8%)

Value:

$6.9B(+6.9%)

BICYCLE THERAPEUTICS PLC

BCYC|088786108

767016(-39.9%)

Value:

$6.5B(-63.5%)

Beam Therapeutics Inc.

BEAM|07373V105

315765

Value:

$6.2B

Invivyd, Inc.

IVVD|00534A102

9722254(-9.0%)

Value:

$5.9B(+24.2%)

Xencor Inc

XNCR|98401F105

549439(+9.9%)

Value:

$5.8B(-49.1%)

Regulus Therapeutics Inc.

RGLS|75915K309

3262564(+0.0%)

Value:

$5.7B(+10.8%)

INOVIO PHARMACEUTICALS, INC.

INO|45773H409

3119162(+0.0%)

Value:

$5.1B(-10.9%)

Rapport Therapeutics, Inc.

RAPP|75383L102

457556

Value:

$4.6B

Instrument	Shares		Other Manager	Value
Sage Therapeutics, Inc.(SAGEcusip78667J108)	2.0M	QoQ NEW(+2.0M) YoY NEW(+2.0M)	All Managers (Combined)	$16.2M	QoQ NEW(+$16.2M) YoY NEW(+$16.2M)
Terns Pharmaceuticals, Inc.(TERNcusip880881107)	5.6M	QoQ 0.00% (-0) YoY -8.58% (-523.4K)	All Managers (Combined)	$15.4M	QoQ -50.18% (-$15.5M) YoY -61.53% (-$24.6M)
Korro Bio, Inc.(KRROcusip500946108)	874.6K	QoQ 0.00% (-0) YoY NEW(+874.6K)	All Managers (Combined)	$15.2M	QoQ -54.26% (-$18.1M) YoY NEW(+$15.2M)
Oruka Therapeutics, Inc.(ORKAcusip687604108)	1.4M	QoQ +92.62% (+694.7K) YoY NEW(+1.4M)	All Managers (Combined)	$14.8M	QoQ +1.92% (+$280.2K) YoY NEW(+$14.8M)
Mind Medicine (Mindmed) Inc.(MNMDcusip60255C885)	2.5M	QoQ -11.24% (-316.6K) YoY -62.50% (-4.2M)	All Managers (Combined)	$14.6M	QoQ -25.39% (-$5.0M) YoY -76.66% (-$48.0M)
Upstream Bio, Inc.(UPBcusip91678A107)	2.3M	QoQ +129.95% (-1.3M) YoY NEW(+2.3M)	All Managers (Combined)	$14.1M	QoQ -14.39% (-$2.4M) YoY NEW(+$14.1M)
Olema Pharmaceuticals, Inc.(OLMAcusip68062P106)	3.4M	QoQ 0.00% (-0) YoY +6.74% (-217.4K)	All Managers (Combined)	$12.9M	QoQ -35.50% (-$7.1M) YoY -64.54% (-$23.6M)
Septerna, Inc.(SEPNcusip81734D104)	1.9M	QoQ 0.00% (-0) YoY NEW(+1.9M)	All Managers (Combined)	$11.1M	QoQ -74.71% (-$32.7M) YoY NEW(+$11.1M)
Novavax Inc(NVAXcusip670002401)	1.5M	QoQ -24.09% (-481.8K) YoY NEW(+1.5M)	All Managers (Combined)	$9.7M	QoQ -39.48% (-$6.3M) YoY NEW(+$9.7M)
Cybin Inc.(CYBNcusip23256X407)	1.5M	QoQ 0.00% (-0) YoY NEW(+1.5M)	All Managers (Combined)	$9.7M	QoQ -28.11% (-$3.8M) YoY NEW(+$9.7M)
Rapt Therapeutics, Inc.(RAPTcusip75382E109)	6.0M	QoQ 0.00% (-0) YoY NEW(+6.0M)	All Managers (Combined)	$7.3M	QoQ -22.78% (-$2.2M) YoY NEW(+$7.3M)
Pliant Therapeutics, Inc.(PLRXcusip729139105)	5.4M	QoQ -9.58% (-572.6K) YoY -6.09% (-350.3K)	All Managers (Combined)	$7.3M	QoQ -90.73% (-$71.4M) YoY -91.49% (-$78.4M)
Avalo Therapeutics, Inc.(AVTXcusip05338F306)	859.9K	QoQ -0.82% (-7.1K) YoY NEW(+859.9K)	All Managers (Combined)	$6.9M	QoQ +6.92% (-$445.8K) YoY NEW(+$6.9M)
Bicycle Therapeutics Plc(BCYCcusip088786108)	767.0K	QoQ -39.89% (-509.1K) YoY -78.02% (-2.7M)	All Managers (Combined)	$6.5M	QoQ -63.54% (-$11.4M) YoY -92.50% (-$80.4M)
Beam Therapeutics Inc.(BEAMcusip07373V105)	315.8K	QoQ NEW(+315.8K) YoY NEW(+315.8K)	All Managers (Combined)	$6.2M	QoQ NEW(+$6.2M) YoY NEW(+$6.2M)
Invivyd, Inc.(IVVDcusip00534A102)	9.7M	QoQ -9.04% (-967.3K) YoY -11.24% (-1.2M)	All Managers (Combined)	$5.9M	QoQ +24.24% (-$1.1M) YoY -87.90% (-$42.8M)
Xencor Inc(XNCRcusip98401F105)	549.4K	QoQ +9.88% (-49.4K) YoY NEW(+549.4K)	All Managers (Combined)	$5.8M	QoQ -49.12% (-$5.6M) YoY NEW(+$5.8M)
Regulus Therapeutics Inc.(RGLScusip75915K309)	3.3M	QoQ 0.00% (+0) YoY -0.12% (-4.0K)	All Managers (Combined)	$5.7M	QoQ +10.75% (+$554.6K) YoY -39.31% (-$3.7M)
Inovio Pharmaceuticals, Inc.(INOcusip45773H409)	3.1M	QoQ 0.00% (-0) YoY NEW(+3.1M)	All Managers (Combined)	$5.1M	QoQ -10.92% (-$623.8K) YoY NEW(+$5.1M)
Rapport Therapeutics, Inc.(RAPPcusip75383L102)	457.6K	QoQ NEW(+457.6K) YoY NEW(+457.6K)	All Managers (Combined)	$4.6M	QoQ NEW(+$4.6M) YoY NEW(+$4.6M)